Pasithea Therapeutics (NASDAQ: KTTA) names Chief Medical Officer as reporting insider on Form 3

Rhea-AI Filing Summary

Pasithea Therapeutics Corp. filed an initial Form 3 for Kartik Krishnan, who serves as Chief Medical Officer. The filing establishes his status as an officer and a reportable insider of the company but does not list any share holdings or recent transactions.

Key Terms

Form 3, Chief Medical Officer, reportable insider

3 terms

Form 3 regulatory

"filed an initial Form 3 for Kartik Krishnan"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Chief Medical Officer financial

"Kartik Krishnan, who serves as Chief Medical Officer"

A chief medical officer is a senior executive responsible for overseeing the health and medical strategies within an organization, often in the healthcare or pharmaceutical sectors. They play a key role in guiding decisions related to medical research, product safety, and healthcare policies, which can impact a company's reputation and success. For investors, understanding the chief medical officer's role helps gauge how well a company manages medical risks and advances its healthcare goals.

reportable insider regulatory

"establishes his status as an officer and a reportable insider"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Krishnan Kartik

(Last) (First) (Middle)

1111 LINCOLN ROAD

SUITE 500

(Street)

MIAMI BEACH FLORIDA 33139

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/01/2026

3. Issuer Name and Ticker or Trading Symbol
Pasithea Therapeutics Corp. [ KTTA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Kartik Krishnan	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Pasithea Therapeutics (KTTA) Form 3 for Kartik Krishnan show?

The Form 3 identifies Kartik Krishnan as Chief Medical Officer and a reportable insider of Pasithea Therapeutics. It serves as an initial ownership statement but does not include any reported holdings or transactions in KTTA securities.

Did Kartik Krishnan buy or sell KTTA shares in this Form 3 filing?

No transactions are reported in this Form 3 for Kartik Krishnan. The insider filing only establishes his status as an officer and reporting person at Pasithea Therapeutics, with no buys, sells, or derivative exercises disclosed.

Does the KTTA Form 3 disclose how many shares Kartik Krishnan owns?

The provided Form 3 data does not show any specific share holdings for Kartik Krishnan. It records him as Chief Medical Officer and a reporting insider, but the holding entries and transaction details are all zero in this excerpt.

What is the role of Kartik Krishnan at Pasithea Therapeutics (KTTA)?

Kartik Krishnan is listed as an officer of Pasithea Therapeutics with the title Chief Medical Officer. This senior role makes him a reportable insider, requiring ownership and transaction disclosures on SEC forms such as Form 3.

Why is a Form 3 filed for Pasithea Therapeutics’ Chief Medical Officer?

Form 3 is filed to identify a person as a company insider when they first become subject to reporting rules. For Pasithea Therapeutics, it records Chief Medical Officer Kartik Krishnan as a reporting person, even though no specific holdings or trades are listed here.